Cadmium uptake and metabolism in cultured cells. by Glennås, A & Rugstad, H E
Environmental Health Perspectives
Vol. 54, pp. 45-50, 1984
Cadmium Uptake and Metbolism
in Cultured Cells
by Anne Glennas* and Hans Erik Rugstad*
Cultured cells have been made resistant to otherwise lethal concentrations ofthe toxic
Cd ion, probably by induction ofmetallothionein (MT) synthesis and binding ofCd to the
MT. One human epithelial cell line (HE) and two enzyme-deficient mutants of mouse
fibroblasts (Lcells) (Cl 1D andA9) andtheirCd-resistant substrains with ahigh contentof
MT, have beenusedto studycellularCduptake and metabolism. Forcell survival of"wild
type" cells, the critical level ofintracellular Cd is determined to be around 6 nmole Cd/mg
cell protein. Resistant cells can tolerate Cd levels several times above this concentration,
if the major part of Cd is bound to MT. The technique of perturbed angular correlation
spectroscopy (PAC) has been applied to living Cd-resistant cells. It was shown that > 66%
of Cd in the resistant strains was bound to MT, and that MT is apparently freely
suspended in the cell cytoplasm. Chelating agents differ in toxicity and Cd-releasing
effect on the cells, but apparently remove the non-MT-bound Cd pool. After various
periods of Cd omission, either in vitro or in vivo, growing the cells as tumors in athymic
nude mice, the stability of Cd resistance in these cells seems to be dependent on the
capacity ofcells for de novo synthesis ofMT shortly after re-exposure to the metal.
Introduction
Cultured cells can be adapted to high concen-
trations ofthe toxic cadmium ion, apparently by
induction of synthesis of the Cd-binding protein
metallothionein (MT) (1,2). This is one ofseveral
indications that MT probably plays a role in Cd
detoxification (3). We have recently obtained
results which indicate that MT may protect cells
from toxic effects of other metals (4) and metal-
containingdrugs (5), as well as certain alkylating
agents (6) and ionizing radiation (7). In view of
thevariouspossible biological functions ofMT, we
alsohave found it ofinterest, in our laboratory, to
evaluate the importance of MT as a protective
factor against cadmium toxicity. It is the purpose
of this paper to present these studies, which are
performed mainly as in vitro studies on cultured
cells.
Cd Resistance and MT Levels in
Cultured Cells
Rugstad and Norseth have described the devel-
opment of Cd-resistant substrains of a human
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epithelial cell line (1) and two enzyme-deficient
mutants of mouse fibroblasts (b-cells) (2). The
human cells were derived from normal skin, and
their epithelial origin was confirmed by phase
contrast microscopy and electron microscopy (8).
Their human origin was demonstrated by isoen-
zyme studies and by typing surface antigens by a
microcytotoxicity assay (8). The murine cells
were two different fibroblast lines: one is desig-
nated clone 1D and is deficient in thymidine ki-
nase; the other is designated A9 and is deficient
in hypoxanthine-guanine phosphoribosyl trans-
ferase. Substrains resistant to otherwise letal
doses of CdCl2, namely 100 gmole/L of culture
medium, were developed from all three parent
cell lines. This was performedby exposingcells to
stepwise increased concentrations of CdCl2. The
lysates of the Cd-resistant cells, but not those
from nonresistant cells, contained large amounts
of low molecular weight cadmium binding pro-
teins. These proteins were determined to be me-
tallothionein (MT) by amino acid analysis (5).
There is good evidence that the resistance in
these cells is due to induced synthesis ofMT and
binding ofCd to MT, thereby protecting the cells
from the otherwise lethal effect ofsuch high total
intracellular concentrations ofcadmium.
We also suggest that the pattern of develop-GLENNAS AND RUGSTAD
ment of Cd resistance in these cells might be
compatible with an amplification ofthe MT gene.
These cells have been used for further studies
on Cd metabolism and experiments to reveal
functions ofthe MT. Culture methods and experi-
mental conditions are detailed elsewhere (9-12).
Results
Cd Content and Egress from Cells
with and without MT
One ofthe most common mechanisms ofresist-
ance to drugsorothertoxic substances isthe cells'
ability to reduce the intracellular concentration
of the substance concerned. This may be caused
either by reduced uptake or enhanced efflux from
cells. Bakka and Rugstad (9) have investigated
the concentration ofCd in the three Cd-resistant
cell strains, compared to their parent cell lines by
exposing cells to [109Cd]-CdCl2, to reveal whether
or not decreased amounts of intracellular Cd
might contribute to the Cd resistance in these
cells. The resultswereprincipally the same for all
three Cd-resistant substrains used. Figure 1
shows the results from experiments with the
concentration of cellular Cd much higher than
thatwhich after about 8 hrincubation injuredthe
nonresistant cells to a degree not compatible with
further growth. The critical level ofintracellular
Cd which cannot be exceeded without lethal con-
sequences on nonresistant cells seems to be 6-8
nmole/mg cell protein, whereas the resistant cells
contained 20-30 nmole/mg after 24 hr growth
with CdCl2. At that point the resistant cells still
had a normal appearance as judged by phase
contrast microscopy and were capable of ap-
parently normal growth. After omission of Cd
fromthe medium, the egress ofCdduringthefirst
2 hroccurredmore rapidly andto agreaterextent
from the nonresistant strain than from the resist-
ant strain. Afterabout 2 hr, the Cdegresswasthe
same from both cell strains.
Recent experiments in which the Cd-resistant
MT-containing substrain of human epithelial
cells was exposed to gold (III) chloride show that
these cells in addition are resistant to concentra-
tions of gold chloride which are lethal to the
parent cell line, and that the Cd-resistant cell
strain is capable ofgrowingwith a higher concen-
tration ofintracellular gold than that which kills
the nonresistant cell strain (4).
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FIGURE 1. Content of Cd (0) in Cl 1D and (0) Cl lDloo cells
after incubation in culture medium containing 100 jmole
CdCl2/L. Cl lD1oo cells were previously adapted to the
same concentration ofCdCl2 and contained high amounts
of metallothionein. (----) Release of Cd from cells growing
in medium without Cd, following 3 hr preincubation with
100 1imole Cd/L. The arrow indicates start ofrelease exper-
iment. Each point represents the mean ± SD from 12
cultures. From Bakka and Rugstad (9) with permission
from thejournal.
clone lDloo cells. There was no significant differ-
ence in Cd content between the Cd-resistant
strains and the nonresistant parent cell lines
during the first 4 hr of incubation. After that
point, the resistant strain proliferated with a
Cd-Depleting Effect ofChelating
Agents
One of the main problems in treatment of Cd
poisoning in humans is the relative inefficiently
chelation therapy. One probable reason is that
most of the Cd is tightly bound to intracellular
proteins, in particular to MT. An efficient chelat-
ing agent has to meet several requirements: the
chelating agentmusthave acceptable toxiceffects
on cells; the complex of the chelating agent and
the metal must have acceptable toxic effects; the
chelating agent must penetrate into the cells; the
complex of the chelating agent and the metal
must be released from cells; and the complex
must be excreted from the body. Cultured cells
with a high content ofCd and MT are considered
tobe auseful in vitromodel forprimary screening
of different chelating agents regarding some of
these requirements, especially those concerning
potentially toxic effects of the substances them-
selves and their ability to increase the release of
Cd from the cells. The term "release" is used to
designate the overall transfer ofmetal from cells
to the growth medium. Bakka et al. (10) studied
the effect of six different metal chelating com-
pounds on cell growth of the Cd-resistant, MT-
containing substrain ofthe human epithelial cell
line and also the effect ofchelators onthe efflux of
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Cd from the cells. The release of 109Cd from cells
under influence ofsome ofthe chelating agents is
shown in Figure 2. Of all the substances tested,
2,3-dimercaptopropane-1-sulfonate (BAL-sulph.)
caused the most rapid release of Cd from cells
during the initial 2 hr incubation, whereas 2,3-
dimercapto-l-propanol (BAL) and mercaptosuc-
cinic acid (MSA) were the most potent Cd-releas-
ers duringthe first 24 hr ofexposure. The toxicity
studies determining cell growth during the influ-
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FIGURE 2. Release of 109Cd into the culture medium from
human epithelial cells (HE100) previously adapted to 100
gmole CdCl2/L culture medium, and containing high
amounts ofmetallothionein during treatment with chelat-
ing agents at equimolar concentrations of 1 mmole/L: (A)
control cells grown (0) without addition ofchelating agent,
(i) grown with 2, 3-dimercaptopropane-1-sulfonate (BAL-
sulph.) and (*VA) grown with 2, 3-dimercapto-1-propanol
(BAL); (B) controls grown (0) without agent; (C) cells
grown with D-penicillamine (PA) and (U) with N-acetyl-
DL-penicillamine (NAPA); (C) controls (0) without agent;
(A) cells grown with BAL-sulph., (A) with mercaptosuccinic
acid and (A) with meso-2,3-dimercaptosuccinic acid
(DMSA). Ordinate gives the CPM per volume unit of the
medium, abscissa indicates time from onset of chelator
exposure. Each point gives the mean ± SD of6 replicates.
From Bakka et al. (10) with permission from thejournal.
A
1
10"
l4
13.
10e
2
Days
B
o-o withoutCd
o----c° 5OPM Cd
o 0---- a IOOPM Cd
1 2 3
CI1D0"normal"
ii-~wIthout Cd
c--o5O1iM Cd
----1lOOPM Cd
1 2
Days
3
FIGURE 3. Cell growth during re-exposure to 50 or 100 gmole
Cd/L culture medium, and in the absence of Cd, of previ-
ously Cd-adapted human epithelial cells (HE100) (A, C) and
mouse fibroblasts (Cl lD1oo) (B, D), following omission of
Cd for 1 week (upper panel) or 3 weeks (lower panel). Both
cell strains had previously been adapted to 100 gmole of
Cd/L. Growth rates of the cells grown continuously with
100 jimole Cd/L (designated "normal") are demonstrated in
the lowerpanel. Ordinate: Cell number (logarithmic scale).
Abscissa: Time from onset ofCd re-exposure. Each point is
the median of six replicates; bars represent the 25th and
75th percentiles for the distribution of cell counts. From
Endresen et al. (11) with permission from thejournal.
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ence of the chelating agents revealed that BAL
was more toxic to the cells than the other agents,
indicating that the egress ofCd from cells caused
by that agent to some degree probably was a
leakage of Cd from cells with injured plasma
membrane.
Stability ofCd Resistance and MT
Levels
The possible biological function of MT as a
detoxifying substance for Cd called for investiga-
tions on stability ofthe Cd resistance and the MT
levels in Cd-adapted cultured cells, both of hu-
man and murine origin. Endresen et al. (11) ex-
pressed the degree ofstability ofCd resistance as
variations incell growth duringre-exposure to Cd
following a period of omission of Cd from the
culture medium (Fig. 3). After a 3-week omission
period, the resistance was the same in the murine
cells, but decreased in the human cell strain to
50% of initial values. Elution profiles obtained
after gel filtration of cytosols (Fig. 4) revealed
thatafter3weeksthere wasnodetectable MTleft
in any of the two strains. Both strains had the
capacity ofrapid de novo MT synthesis even after
5 weeks without Cd. This capacity was best pre-
served in the mouse fibroblast strain, in which
80% ofthe previous levels ofMT (during continu-
ous growth in Cd-containing medium) could be
demonstrated after 24 hr re-exposure to maxi-
mum tolerable doses, whereas only 60% was at-
tained in the human cell strain.
Discussion
There is a striking difference in Cd tolerance
between cultured cells, either human or murine,
previously being adapted to 100 pmole Cd/L cul-
ture medium and the parent cells not previously
exposed to Cd. The critical level of intracellular
Cd in the parent cells described is about 6 nmole/
mg cell protein, whereas the Cd-adapted strains
growcontinuously atlevels 4to 7 timeshigher. In
the resistant strains, 95% ofthe intracellular Cd
is bound to MT, as determined by gel filtration
elution profiles. Thus the level ofCd not bound to
MT is well below the level which is lethal to the
parentcells. It is suggested that the binding ofCd
to MT also explains the slow release of Cd from
these cells compared to the parent cells, when Cd
is removed from the medium. Bakka et al. (12)
also used another method to study the binding
modes of Cd in cells, namely, the spectroscopic
technique of perturbed angular correlation of y-
rays (PAC). As far as we know, this is the first
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FIGURE 4. Elution profiles obtained after Sephadex G-75
chromatography of cytosols from previously Cd-adapted
substrains ofhuman epithelial cells(HE10o) (A, C, E), and
mouse fibroblasts (Cl lDloo) (B,D,F), both previouslybeen
grown with 100 imole Cd/L culture medium. The upper
panels (A, B) demonstrate the "normal" Cd-adapted state
ofthe cell strains, the lower panels (E, F) show the elution
profiles for the cells after being cultured for 3 weeks
without Cd-supplement, and the panels in the middle (C,
D) theprofiles after5 weeks withoutCd and subsequent re-
exposure for 24 hr to maximal tolerable doses, that is 50
imole Cd/L for theHE10o cells and 100 gimole Cd/L for the
lDloo cells. All data are expressed as metal concentration
in each fraction and are normalized to 1 mg of cytosolic
protein applied to the column. The peak eluting with
fractions 20-25 represents the high molecular weight pro-
teins (MW>75,000); the peak eluting with fractions 35-45
contains the metallothioneins (MW-10,000). From Endre-
sen et al. (11) with permission from thejournal.
time PAC has been used for this purpose (13) in
living cultured cells. Those studies confirm the
conclusionthatthere are two differenttypes ofCd
binding sites within cells. MT constitutes the
main one, binding >60% of the Cd. Additional
importantinformation isthatthis MTapparently
is freely suspended in the cytoplasm ofthe cells.
Thus, there is good evidence that MT is one main
protecting factor against the toxic Cd ion in these
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cells and that mechanisms leading to decreased
concentration ofCd in the cells does not seem to
be at work. This is in agreement with the sug-
gested role of MT regarding resistance against
gold (III) chloride. The fact that gold binds to the
pre-existent Cd-induced MT in the Cd-resistant
human epithelial cell strain probably protects
cells from the otherwise lethal gold concentration
(4).
Also the study on the effect and toxicity of
chelating agents led to the assumption that Cd
exists in at least two pools within the cells. One
rather small part of the Cd is relatively loosely
bound and can easily be removed within a few
hours by a chelating agent. The other is tightly
bound within cells and is removed slowly. It
seems plausible to suggest that the small, loosely
bound fraction represents a more toxic threat to
the cells than doesthe majorpool, which probably
comprises the MT-bound Cd. An efficient chelat-
ing agent should preferably be able to release Cd
from both pools. This capacity will be dependent
on the relative affinities of Cd to the chelator
versus the MT. None of the compounds tested
appeared to have the capacity of releasing more
than minor amounts of Cd bound to MT. It ap-
pears reasonable to test new chelators in systems
including MT, and the in vitro system described
by Bakka et al. (10) seems to be a promising
system for primary screening of effect and toxic-
ity of such agents. The high toxicity of BAL has
also been demonstrated by others in studies on
mice (14). The superior releasing effect ofMSA in
vitro calls for further investigation in vivo.
The demonstrated stability ofthe Cd-resistance
in previously Cd-treated cell strains of both hu-
man and murine origin might be due to their
capacity ofimmediate de novo MTsynthesis when
re-exposed to the Cd ion. This has also been
demonstrated by in vivo studies, in which the
murine cells were grown as tumors in athymic
nude mice, that is, in the absence ofCd, and then
re-exposed them to Cd after plating the tumor
cells either in tissue culture flasks or in soft agar
(11). This mechanism ofpreserving the acquired
Cd resistance is compatible with the evidence
presented by Hildebrand et al. (15) regarding Cd
resistance in cultured CHO cells. In terms of
genetics, the explanation for the difference in
capacity for de novo MT synthesis between the
murine and human cell strain is not yet known.
One might speculate that differences in degree of
amplification of the MT gene account for this
difference. It is reported (16) that gene amplifica-
tion occurs in Cd-resistant Friend leukemia cells,
when comparedto theirparent nonresistant cells.
Conclusions
Studies on Cd uptake and metabolism in cul-
tured murine and human cell strains with and
without Cd-induced MT have revealed the follow-
ing.
(1) The amount ofnon-MT-bound Cd seems de-
cisive for Cd toxicity in cells. The critical level
seems tobe about 6nmole/mgcell protein inthree
different cell lines. Theresistant cells cantolerate
total amounts of intracellular Cd which are sev-
eral times higher, if the major part is bound to
MT, and the pool of non-MT-bound Cd does not
exceed this critical level.
(2) The PAC technique is well suited to study
binding modes ofCd in living cells and indicates
that the cellular Cd is mainly bound to MT and
that Cd-containing MT molecules are freely sus-
pended in the cell cytoplasm.
(3) An in vitro model ofcultured cells contain-
ing MT seems to be a promising test system for
primary screening of effect and toxicity of new
chelators. Chelating agents apparently remove
the non-MT-bound Cd pool in cells. MSA seems
more efficient and less toxic than BAL.
(4) The stability of Cd resistance varies be-
tween human epithelial cells and mouse fibro-
blasts in culture. The evidence presented is in
agreement with the concept that resistance to the
potent MT-inducing metal Cd is stable due to the
capacity of cells for de novo synthesis of MT
shortly after re-exposure to the metal, both in
vitro and in vivo.
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